Clinical Trials

A critical element in the development of drug products to treat a variety of diseases and illnesses throughout the world is the conduct of clinical trials in human subjects. The results of human drug trials help assess the safety and efficacy of drugs and drug candidates for use in patient populations.

Safety of study subjects is always Abbott’s highest priority in conducting clinical trials.

Healthy volunteers and patients who are interested in participating in our clinical studies undergo a full discussion of the process with clinical professionals and appropriate medical screening before entering the clinical trial.

Canadian physicians and patients continue to contribute a great deal to Abbott’s clinical trials. It is valuable for Canadian physicians to gain experience with innovative treatments before they are introduced to the market. This allows the physician and Health Canada to have clearer insight into the treatments themselves, but also to understand how they will fit into our health care system.

Abbott Policy on Clinical Trials Involving Pharmaceutical Products

To access a list of clinical trials involving drug and drug candidates being conducted by Abbott please visit the ClinicalTrials.gov Web site. Click on “List by Sponsor” and then on “Industry.” Information about each trial’s purpose, who may participate, locations, and phone numbers for more details is provided with each trial. After clicking on “Abbott,” you may “Search within Results,” and enter “Canada” to view the trials currently ongoing in Canada.

In addition to information on clinical trials under way, it is Abbott’s policy to publicly disclose the results of controlled clinical trials of drugs and drug candidates subsequently approved for marketing regardless of outcome.

For more information, please visit the Abbott Global Web site.